CSL Limited Rating Reiterated by Credit Suisse (CSL)
CSL Limited (ASX:CSL)‘s stock had its “outperform” rating reiterated by equities research analysts at Credit Suisse in a research note issued to investors on Friday, AnalystRatings.Net reports. They currently have a $74.55 price objective on the stock.
A number of other firms have also recently commented on CSL. Analysts at Deutsche Bank raised their price target on shares of CSL Limited from $71.00 to $78.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of A$73.76 ($64.70).
Shares of CSL Limited (ASX:CSL) traded up 1.06% during mid-day trading on Friday, hitting A$70.870. The stock had a trading volume of 1,007,519 shares. CSL Limited has a 52 week low of A$52.250 and a 52 week high of A$71.130. The stock’s 50-day moving average is A$68.16 and its 200-day moving average is A$66.86. The company has a market cap of A$34.539 billion and a P/E ratio of 28.85.
CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.